Transform harvested fat into cleaner, more refined graft material
Celcore clinical solutions transform harvested adipose tissue into refined graft material by concentrating structural
and cellular components while removing unwanted inflammatory residue. The result is a more optimized graft with stronger structural support, higher regenerative potential, and improved clinical utility.
Celcore Solution by the Numbers
(vs raw unprocessed lipoaspirate)
8.5×
Less free oil
— reduced from
~17% to ~2%, removing inflammatory residue that works against graft survival.
8×
4×
1.5×
More viable and robust adipocytes
— from ~41% to ~61%,
for improved
volume retention.
Svalgaard & Munthe-Fog, Scientific White Paper 2026
Science
Adipose tissue contains powerful building blocks: extracellular matrix, stromal vascular fraction (SVF), viable adipocytes and growth factors. Together, these components deliver both structural volume
and regenerative quality. Celcore solutions preserve what supports graft performance and remove what compromises it.
Products / Applications
Our clinical solutions fit directly into the clinical workflow, allowing physicians to refine a patient’s own fat in a single procedure for immediate use. Applications include facial volume and rejuvenation, body contouring, reconstruction and selected orthopaedic use.
Pipeline
Celcore is evolving beyond clinical solutions for autologous processing into off-the-shelf extracellular matrix products.
Our pipeline includes pre-filled ECM syringes designed for correction of dermal and subcutaneous tissue deficiencies without liposuction or tissue processing — expanding biomaterials into broader care settings.
In development; not available for sale.
Partners
Partner with Celcore to bring next-generation biomaterials to surgeons and clinics across Europe.
Our platform combines high-quality EU-regulated products, clinically practical workflows, and a growing pipeline designed for long-term commercial value.
